Article
Evaluation of a recombinant double mutant of staphylococcal enterotoxin B (SEB-H32Q/K173E) with enhanced antitumor activity effects and decreased pyrexia.
PloS one - 1 Jan 2013
Gu Liwei, Yue Junjie, Zheng Yuling, Zheng Xin, Wang Jun, Wang Yanzi, Li Jianchun, Jiang Yongqiang, Jiang Hua
Abstract excerpt
BACKGROUND: Immunotherapy has been used to improve patient immune function, inhibit tumor growth and has become a highly promising method of cancer treatment. Highly agglutinative staphylococcin (HAS), a mixture of Staphylococcus aureus culture filtrates, which include staphylococcal enterotoxin (SE) C as the active ingredient, has been used clinically as an immunomodifier in the treatment of a number of tumors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
